Beta-Glucan Particles as Vaccine Adjuvant Carriers

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Glucan particles (GPs) are derived from Saccharomyces cerevisiae cell walls, primarily composed of β-1, 3-D-glucans.
• GPs feature an internal hollow cavity suitable for encapsulating various compounds, including protein antigens.
• The inherent immunostimulatory properties of β-glucan contribute to the adjuvant potential of GPs.

Purpose of the Study:

• To detail the production and characterization of glucan particles (GPs).
• To present a protocol for loading model and pathogen-specific antigens into GPs.
• To establish GPs as a dual-function delivery system and adjuvant for vaccine research.

Main Methods:

• Production of GPs via hot alkaline and solvent extraction from Saccharomyces cerevisiae.
• Characterization of GPs for morphology, particle density, and hydrodynamic volume.
• Loading of ovalbumin (OVA) and pathogen-specific antigens into GPs using yeast RNA.

Main Results:

• Successful production and characterization of hollow glucan particles.
• Demonstrated protocol for efficient antigen loading into GPs.
• Established GPs as a versatile platform for antigen delivery and immune stimulation.

Conclusions:

• Glucan particles are a viable biomaterial for targeted antigen delivery to antigen-presenting cells.
• The GP system acts as both a delivery vehicle and an adjuvant, enhancing immune responses.
• The described methods facilitate the use of GPs in developing novel vaccination strategies.